CDH11 Biomarkers for diagnosing malignant mesothelioma CDH11 and their uses

摘要

The present invention relates to a biomarker CDH11 for diagnosing malignant mesothelioma and uses thereof. Specifically, a malignant mesothelioma diagnostic gene, CDH11 is selected by bioinformatics analysis, and it is confirmed that the gene has high expression levels in tissue samples from patients with mesothelioma. Therefore, the gene can be used as a biomarker for the diagnosis of malignant mesothelioma.